Which has better valuation & earnings, ATRC or INMD?

InMode has lower revenue, but higher earnings than AtriCure. InMode is trading at a lower price-to-earnings ratio than AtriCure, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AtriCure $534.53M 5.03 -$11.45M $0.21 251.62 InMode $370.49M 2.18 $93.83M $1.23 11.45

Is ATRC or INMD more profitable?

InMode has a net margin of 20.69% compared to AtriCure's net margin of 1.85%. InMode's return on equity of 11.99% beat AtriCure's return on equity. Company Net Margins Return on Equity Return on Assets AtriCure 1.85% 2.34% 1.77% InMode 20.69% 11.99% 10.60%

Does the media refer more to ATRC or INMD?

In the previous week, AtriCure had 2 more articles in the media than InMode. MarketBeat recorded 4 mentions for AtriCure and 2 mentions for InMode. AtriCure's average media sentiment score of 0.22 beat InMode's score of 0.13 indicating that AtriCure is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AtriCure 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral InMode 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher earnings and valuation, INMD or TMDX?

TransMedics Group has higher revenue and earnings than InMode. InMode is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InMode $370.49M 2.18 $93.83M $1.23 11.45 TransMedics Group $605.49M 4.51 $190.29M $3.89 20.31

Does the media refer more to INMD or TMDX?

In the previous week, TransMedics Group had 11 more articles in the media than InMode. MarketBeat recorded 13 mentions for TransMedics Group and 2 mentions for InMode. TransMedics Group's average media sentiment score of 0.52 beat InMode's score of 0.13 indicating that TransMedics Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InMode 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral TransMedics Group 4 Very Positive mention(s) 2 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, BFLY or INMD?

InMode has higher revenue and earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Butterfly Network $97.61M 21.81 -$77.06M -$0.29 N/A InMode $370.49M 2.18 $93.83M $1.23 11.45

Is BFLY or INMD more profitable?

InMode has a net margin of 20.69% compared to Butterfly Network's net margin of -66.74%. InMode's return on equity of 11.99% beat Butterfly Network's return on equity. Company Net Margins Return on Equity Return on Assets Butterfly Network -66.74% -33.99% -22.96% InMode 20.69% 11.99% 10.60%

Does the media prefer BFLY or INMD?

In the previous week, Butterfly Network had 16 more articles in the media than InMode. MarketBeat recorded 18 mentions for Butterfly Network and 2 mentions for InMode. Butterfly Network's average media sentiment score of 0.28 beat InMode's score of 0.13 indicating that Butterfly Network is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Butterfly Network 4 Very Positive mention(s) 1 Positive mention(s) 11 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral InMode 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has preferable valuation and earnings, INMD or INSP?

Inspire Medical Systems has higher revenue and earnings than InMode. InMode is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio InMode $370.49M 2.18 $93.83M $1.23 11.45 Inspire Medical Systems $911.98M 2.11 $145.42M $4.62 14.39

Does the media prefer INMD or INSP?

In the previous week, Inspire Medical Systems had 6 more articles in the media than InMode. MarketBeat recorded 8 mentions for Inspire Medical Systems and 2 mentions for InMode. Inspire Medical Systems' average media sentiment score of 0.93 beat InMode's score of 0.13 indicating that Inspire Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment InMode 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Inspire Medical Systems 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, AXGN or INMD?

InMode has higher revenue and earnings than AxoGen. AxoGen is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AxoGen $225.21M 8.64 -$15.70M -$0.68 N/A InMode $370.49M 2.18 $93.83M $1.23 11.45

Is AXGN or INMD more profitable?

InMode has a net margin of 20.69% compared to AxoGen's net margin of -13.36%. InMode's return on equity of 11.99% beat AxoGen's return on equity. Company Net Margins Return on Equity Return on Assets AxoGen -13.36% -8.90% -6.47% InMode 20.69% 11.99% 10.60%

Does the media refer more to AXGN or INMD?

In the previous week, AxoGen had 11 more articles in the media than InMode. MarketBeat recorded 13 mentions for AxoGen and 2 mentions for InMode. AxoGen's average media sentiment score of 0.14 beat InMode's score of 0.13 indicating that AxoGen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AxoGen 2 Very Positive mention(s) 1 Positive mention(s) 7 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral InMode 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

InMode (INMD) Competitors

$14.20 +0.12 (+0.82%)

As of 02:26 PM Eastern

Compare

INMD vs. ATRC, TMDX, BFLY, INSP, and AXGN

Should you buy InMode stock or one of its competitors? InMode's main competitors and comparable companies include AtriCure (ATRC), TransMedics Group (TMDX), Butterfly Network (BFLY), Inspire Medical Systems (INSP), and AxoGen (AXGN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does InMode compare to AtriCure?

AtriCure (NASDAQ:ATRC) and InMode (NASDAQ:INMD) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their profitability, dividends, risk, earnings, analyst recommendations, valuation, media sentiment and institutional ownership.

InMode has a net margin of 20.69% compared to AtriCure's net margin of 1.85%. InMode's return on equity of 11.99% beat AtriCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AtriCure	1.85%	2.34%	1.77%
InMode	20.69%	11.99%	10.60%

AtriCure currently has a consensus target price of $53.30, indicating a potential upside of 0.87%. InMode has a consensus target price of $16.00, indicating a potential upside of 13.64%. Given InMode's higher possible upside, analysts plainly believe InMode is more favorable than AtriCure.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AtriCure	0 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.58
InMode	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

InMode has lower revenue, but higher earnings than AtriCure. InMode is trading at a lower price-to-earnings ratio than AtriCure, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AtriCure	$534.53M	5.03	-$11.45M	$0.21	251.62
InMode	$370.49M	2.18	$93.83M	$1.23	11.45

99.1% of AtriCure shares are held by institutional investors. Comparatively, 68.0% of InMode shares are held by institutional investors. 4.0% of AtriCure shares are held by insiders. Comparatively, 6.9% of InMode shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

AtriCure has a beta of 1.24, meaning that its stock price is 24% more volatile than the broader market. Comparatively, InMode has a beta of 2.03, meaning that its stock price is 103% more volatile than the broader market.

In the previous week, AtriCure had 2 more articles in the media than InMode. MarketBeat recorded 4 mentions for AtriCure and 2 mentions for InMode. AtriCure's average media sentiment score of 0.22 beat InMode's score of 0.13 indicating that AtriCure is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AtriCure	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
InMode	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

AtriCure and InMode tied by winning 8 of the 16 factors compared between the two stocks.

How does InMode compare to TransMedics Group?

InMode (NASDAQ:INMD) and TransMedics Group (NASDAQ:TMDX) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, institutional ownership, valuation, media sentiment, analyst recommendations, risk, profitability and earnings.

TransMedics Group has a net margin of 22.69% compared to InMode's net margin of 20.69%. TransMedics Group's return on equity of 15.88% beat InMode's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InMode	20.69%	11.99%	10.60%
TransMedics Group	22.69%	15.88%	5.95%

68.0% of InMode shares are owned by institutional investors. Comparatively, 99.7% of TransMedics Group shares are owned by institutional investors. 6.9% of InMode shares are owned by insiders. Comparatively, 6.9% of TransMedics Group shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

InMode has a beta of 2.03, indicating that its stock price is 103% more volatile than the broader market. Comparatively, TransMedics Group has a beta of 1.94, indicating that its stock price is 94% more volatile than the broader market.

TransMedics Group has higher revenue and earnings than InMode. InMode is trading at a lower price-to-earnings ratio than TransMedics Group, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InMode	$370.49M	2.18	$93.83M	$1.23	11.45
TransMedics Group	$605.49M	4.51	$190.29M	$3.89	20.31

In the previous week, TransMedics Group had 11 more articles in the media than InMode. MarketBeat recorded 13 mentions for TransMedics Group and 2 mentions for InMode. TransMedics Group's average media sentiment score of 0.52 beat InMode's score of 0.13 indicating that TransMedics Group is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InMode	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
TransMedics Group	4 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

InMode currently has a consensus target price of $16.00, indicating a potential upside of 13.64%. TransMedics Group has a consensus target price of $121.00, indicating a potential upside of 53.16%. Given TransMedics Group's stronger consensus rating and higher possible upside, analysts plainly believe TransMedics Group is more favorable than InMode.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InMode	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
TransMedics Group	1 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38

Summary

TransMedics Group beats InMode on 13 of the 16 factors compared between the two stocks.

How does InMode compare to Butterfly Network?

Butterfly Network (NYSE:BFLY) and InMode (NASDAQ:INMD) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, media sentiment, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

In the previous week, Butterfly Network had 16 more articles in the media than InMode. MarketBeat recorded 18 mentions for Butterfly Network and 2 mentions for InMode. Butterfly Network's average media sentiment score of 0.28 beat InMode's score of 0.13 indicating that Butterfly Network is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Butterfly Network	4 Very Positive mention(s)	1 Positive mention(s)	11 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
InMode	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Butterfly Network presently has a consensus target price of $8.54, indicating a potential upside of 6.84%. InMode has a consensus target price of $16.00, indicating a potential upside of 13.64%. Given InMode's higher possible upside, analysts plainly believe InMode is more favorable than Butterfly Network.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Butterfly Network	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.71
InMode	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

InMode has higher revenue and earnings than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Butterfly Network	$97.61M	21.81	-$77.06M	-$0.29	N/A
InMode	$370.49M	2.18	$93.83M	$1.23	11.45

37.9% of Butterfly Network shares are held by institutional investors. Comparatively, 68.0% of InMode shares are held by institutional investors. 22.0% of Butterfly Network shares are held by insiders. Comparatively, 6.9% of InMode shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

InMode has a net margin of 20.69% compared to Butterfly Network's net margin of -66.74%. InMode's return on equity of 11.99% beat Butterfly Network's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Butterfly Network	-66.74%	-33.99%	-22.96%
InMode	20.69%	11.99%	10.60%

Butterfly Network has a beta of 2.04, indicating that its stock price is 104% more volatile than the broader market. Comparatively, InMode has a beta of 2.03, indicating that its stock price is 103% more volatile than the broader market.

Summary

InMode beats Butterfly Network on 9 of the 17 factors compared between the two stocks.

How does InMode compare to Inspire Medical Systems?

InMode (NASDAQ:INMD) and Inspire Medical Systems (NYSE:INSP) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, media sentiment, analyst recommendations, earnings, risk, valuation, profitability and institutional ownership.

Inspire Medical Systems has higher revenue and earnings than InMode. InMode is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
InMode	$370.49M	2.18	$93.83M	$1.23	11.45
Inspire Medical Systems	$911.98M	2.11	$145.42M	$4.62	14.39

InMode has a net margin of 20.69% compared to Inspire Medical Systems' net margin of 15.03%. InMode's return on equity of 11.99% beat Inspire Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
InMode	20.69%	11.99%	10.60%
Inspire Medical Systems	15.03%	8.64%	7.45%

68.0% of InMode shares are owned by institutional investors. Comparatively, 94.9% of Inspire Medical Systems shares are owned by institutional investors. 6.9% of InMode shares are owned by insiders. Comparatively, 2.2% of Inspire Medical Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

InMode has a beta of 2.03, indicating that its share price is 103% more volatile than the broader market. Comparatively, Inspire Medical Systems has a beta of 0.73, indicating that its share price is 27% less volatile than the broader market.

InMode currently has a consensus target price of $16.00, indicating a potential upside of 13.64%. Inspire Medical Systems has a consensus target price of $67.29, indicating a potential upside of 1.19%. Given InMode's higher possible upside, research analysts plainly believe InMode is more favorable than Inspire Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
InMode	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Inspire Medical Systems	4 Sell rating(s)	12 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	2.05

In the previous week, Inspire Medical Systems had 6 more articles in the media than InMode. MarketBeat recorded 8 mentions for Inspire Medical Systems and 2 mentions for InMode. Inspire Medical Systems' average media sentiment score of 0.93 beat InMode's score of 0.13 indicating that Inspire Medical Systems is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
InMode	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Inspire Medical Systems	7 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Inspire Medical Systems beats InMode on 10 of the 17 factors compared between the two stocks.

How does InMode compare to AxoGen?

AxoGen (NASDAQ:AXGN) and InMode (NASDAQ:INMD) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their earnings, profitability, dividends, risk, valuation, analyst recommendations, media sentiment and institutional ownership.

80.3% of AxoGen shares are held by institutional investors. Comparatively, 68.0% of InMode shares are held by institutional investors. 2.4% of AxoGen shares are held by insiders. Comparatively, 6.9% of InMode shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

InMode has higher revenue and earnings than AxoGen. AxoGen is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AxoGen	$225.21M	8.64	-$15.70M	-$0.68	N/A
InMode	$370.49M	2.18	$93.83M	$1.23	11.45

InMode has a net margin of 20.69% compared to AxoGen's net margin of -13.36%. InMode's return on equity of 11.99% beat AxoGen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AxoGen	-13.36%	-8.90%	-6.47%
InMode	20.69%	11.99%	10.60%

AxoGen has a beta of 1.17, indicating that its stock price is 17% more volatile than the broader market. Comparatively, InMode has a beta of 2.03, indicating that its stock price is 103% more volatile than the broader market.

AxoGen presently has a consensus target price of $51.70, indicating a potential upside of 42.90%. InMode has a consensus target price of $16.00, indicating a potential upside of 13.64%. Given AxoGen's stronger consensus rating and higher possible upside, equities analysts clearly believe AxoGen is more favorable than InMode.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AxoGen	1 Sell rating(s)	2 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.71
InMode	1 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, AxoGen had 11 more articles in the media than InMode. MarketBeat recorded 13 mentions for AxoGen and 2 mentions for InMode. AxoGen's average media sentiment score of 0.14 beat InMode's score of 0.13 indicating that AxoGen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AxoGen	2 Very Positive mention(s)	1 Positive mention(s)	7 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
InMode	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

InMode beats AxoGen on 9 of the 16 factors compared between the two stocks.

Get InMode News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

INMD vs. The Competition

Export

Metric	InMode	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$815.93M	$5.44B	$7.21B	$13.27B
Dividend Yield	N/A	1.78%	2.53%	16.36%
P/E Ratio	11.54	25.43	274.52	26.15
Price / Sales	2.20	70.42	585.83	81.10
Price / Cash	9.39	32.10	76.82	53.72
Price / Book	1.32	5.90	11.21	6.33
Net Income	$93.83M	$146.18M	$3.50B	$381.74M
7 Day Performance	0.75%	-0.52%	-0.78%	-1.36%
1 Month Performance	-4.02%	-3.46%	-5.37%	-4.29%
1 Year Performance	-10.67%	2.71%	4.65%	-0.24%

InMode Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
INMD InMode	1.709 of 5 stars	$14.20 +0.8%	$16.00 +12.7%	-6.4%	$815.93M	$370.49M	11.54	660
ATRC AtriCure	2.6083 of 5 stars	$56.37 +2.2%	$53.30 -5.4%	+50.6%	$2.80B	$534.53M	268.44	1,350
TMDX TransMedics Group	4.5307 of 5 stars	$82.99 +4.0%	$121.10 +45.9%	-33.1%	$2.76B	$605.49M	21.33	898	News Coverage Analyst Forecast
BFLY Butterfly Network	1.7613 of 5 stars	$9.41 +5.1%	$8.54 -9.2%	+197.2%	$2.38B	$97.61M	N/A	220	News Coverage Insider Trade
INSP Inspire Medical Systems	2.6018 of 5 stars	$70.77 +1.1%	$67.44 -4.7%	-15.3%	$2.02B	$898.74M	15.32	1,333	Positive News Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:INMD) was last updated on 10/9/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

InMode (INMD) Competitors

INMD vs. ATRC, TMDX, BFLY, INSP, and AXGN

How does InMode compare to AtriCure?

Summary

How does InMode compare to TransMedics Group?

Summary

How does InMode compare to Butterfly Network?

Summary

How does InMode compare to Inspire Medical Systems?

Summary

How does InMode compare to AxoGen?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INMD vs. The Competition

InMode Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

InMode (INMD) Competitors

INMD vs. ATRC, TMDX, BFLY, INSP, and AXGN

How does InMode compare to AtriCure?

Is ATRC or INMD more profitable?

Do analysts recommend ATRC or INMD?

Which has better valuation & earnings, ATRC or INMD?

Do insiders & institutionals hold more shares of ATRC or INMD?

Which has more risk & volatility, ATRC or INMD?

Does the media refer more to ATRC or INMD?

Summary

How does InMode compare to TransMedics Group?

Is INMD or TMDX more profitable?

Do institutionals & insiders believe in INMD or TMDX?

Which has more risk & volatility, INMD or TMDX?

Which has higher earnings and valuation, INMD or TMDX?

Does the media refer more to INMD or TMDX?

Do analysts rate INMD or TMDX?

Summary

How does InMode compare to Butterfly Network?

Does the media prefer BFLY or INMD?

Do analysts prefer BFLY or INMD?

Which has better earnings & valuation, BFLY or INMD?

Do institutionals and insiders hold more shares of BFLY or INMD?

Is BFLY or INMD more profitable?

Which has more risk & volatility, BFLY or INMD?

Summary

How does InMode compare to Inspire Medical Systems?

Which has preferable valuation and earnings, INMD or INSP?

Is INMD or INSP more profitable?

Do insiders & institutionals hold more shares of INMD or INSP?

Which has more volatility and risk, INMD or INSP?

Do analysts prefer INMD or INSP?

Does the media prefer INMD or INSP?

Summary

How does InMode compare to AxoGen?

Do institutionals and insiders believe in AXGN or INMD?

Which has higher earnings & valuation, AXGN or INMD?

Is AXGN or INMD more profitable?

Which has more volatility & risk, AXGN or INMD?

Do analysts prefer AXGN or INMD?

Does the media refer more to AXGN or INMD?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INMD vs. The Competition

InMode Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools